- call +1-201-465-4211
- email sales@mrinsights.biz
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life.
Scope of the Report:
This report focuses on the Cancer Supportive Care in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
With growing prevalence of cancer, the demand for cancer treatments, such as chemotherapy has also been consistently on the rise since the past decade. However, radiation therapy brings with it a host of side effects that are challenging for cancer patients to face while they undergo the course of treatment. While the cancer treatment realm is tremendously progressing, the incidences of side effects are increasing as well, which are addressed by cancer supportive care. The advent of technology in cancer supportive care has enabled to treat different signs and symptoms following the chemotherapy procedure, in addition to chemotherapy-induced vomiting, nausea, neutropenia, and anemia. The global market for cancer supportive care products is currently thriving at a sound pace and is anticipated to see steady growth over the next few years.
The high investment in the oncology segment and pharmaceutical industry in US and Canada, and the presence of several large vendors operating in US contribute to the growth of the palliative cancer care market in the Americas. Additionally, constant R&D activities in the oncology sector, strong economic condition, and huge investments in the healthcare segment further contribute to the market growth.
The worldwide market for Cancer Supportive Care is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Amgen
Helsinn Healthcare
Johnson &Johnson
Merck
F. Hoffmann-La Roche
GlaxoSmithKline
Novartis
TESARO
Teva Pharmaceutical Industries
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Nonsteroidal Erythropoietin Stimulating Agents
Opioid Analgesics
Anti-Imflammatory Drugs
Anti-Infective Drugs
Bisphosphonates
Anti-Emetics Drugs
Monoclonal Antibodies
Granulocyte Colony Stimulating Factor
Market Segment by Applications, can be divided into
Lung Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Bladder Cancer
Leukemia
Ovarian Cancer
Melanoma
Others
There are 15 Chapters to deeply display the global Cancer Supportive Care market.
Chapter 1, to describe Cancer Supportive Care Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cancer Supportive Care, with sales, revenue, and price of Cancer Supportive Care, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Supportive Care, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cancer Supportive Care market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cancer Supportive Care sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Cancer Supportive Care Introduction
1.2 Market Analysis by Type
1.2.1 Nonsteroidal Erythropoietin Stimulating Agents
1.2.2 Opioid Analgesics
1.2.3 Anti-Imflammatory Drugs
1.2.4 Anti-Infective Drugs
1.2.5 Bisphosphonates
1.2.6 Anti-Emetics Drugs
1.2.7 Monoclonal Antibodies
1.2.8 Granulocyte Colony Stimulating Factor
1.3 Market Analysis by Applications
1.3.1 Lung Cancer
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Liver Cancer
1.3.5 Bladder Cancer
1.3.6 Leukemia
1.3.7 Ovarian Cancer
1.3.8 Melanoma
1.3.9 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Cancer Supportive Care Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Cancer Supportive Care Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Helsinn Healthcare
2.2.1 Business Overview
2.2.2 Cancer Supportive Care Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Helsinn Healthcare Cancer Supportive Care Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson &Johnson
2.3.1 Business Overview
2.3.2 Cancer Supportive Care Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson &Johnson Cancer Supportive Care Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Cancer Supportive Care Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Cancer Supportive Care Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 F. Hoffmann-La Roche
2.5.1 Business Overview
2.5.2 Cancer Supportive Care Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 F. Hoffmann-La Roche Cancer Supportive Care Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 GlaxoSmithKline
2.6.1 Business Overview
2.6.2 Cancer Supportive Care Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GlaxoSmithKline Cancer Supportive Care Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Cancer Supportive Care Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis Cancer Supportive Care Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 TESARO
2.8.1 Business Overview
2.8.2 Cancer Supportive Care Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 TESARO Cancer Supportive Care Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Teva Pharmaceutical Industries
2.9.1 Business Overview
2.9.2 Cancer Supportive Care Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Teva Pharmaceutical Industries Cancer Supportive Care Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cancer Supportive Care Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cancer Supportive Care Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cancer Supportive Care Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cancer Supportive Care Manufacturer Market Share in 2017
3.3.2 Top 6 Cancer Supportive Care Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cancer Supportive Care Market Analysis by Regions
4.1 Global Cancer Supportive Care Sales, Revenue and Market Share by Regions
4.1.1 Global Cancer Supportive Care Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cancer Supportive Care Revenue and Market Share by Regions (2013-2018)
4.2 North America Cancer Supportive Care Sales and Growth Rate (2013-2018)
4.3 Europe Cancer Supportive Care Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Supportive Care Sales and Growth Rate (2013-2018)
4.5 South America Cancer Supportive Care Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Supportive Care Sales and Growth Rate (2013-2018)
5 North America Cancer Supportive Care by Countries
5.1 North America Cancer Supportive Care Sales, Revenue and Market Share by Countries
5.1.1 North America Cancer Supportive Care Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cancer Supportive Care Revenue and Market Share by Countries (2013-2018)
5.2 United States Cancer Supportive Care Sales and Growth Rate (2013-2018)
5.3 Canada Cancer Supportive Care Sales and Growth Rate (2013-2018)
5.4 Mexico Cancer Supportive Care Sales and Growth Rate (2013-2018)
6 Europe Cancer Supportive Care by Countries
6.1 Europe Cancer Supportive Care Sales, Revenue and Market Share by Countries
6.1.1 Europe Cancer Supportive Care Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cancer Supportive Care Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cancer Supportive Care Sales and Growth Rate (2013-2018)
6.3 UK Cancer Supportive Care Sales and Growth Rate (2013-2018)
6.4 France Cancer Supportive Care Sales and Growth Rate (2013-2018)
6.5 Russia Cancer Supportive Care Sales and Growth Rate (2013-2018)
6.6 Italy Cancer Supportive Care Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cancer Supportive Care by Countries
7.1 Asia-Pacific Cancer Supportive Care Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cancer Supportive Care Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cancer Supportive Care Revenue and Market Share by Countries (2013-2018)
7.2 China Cancer Supportive Care Sales and Growth Rate (2013-2018)
7.3 Japan Cancer Supportive Care Sales and Growth Rate (2013-2018)
7.4 Korea Cancer Supportive Care Sales and Growth Rate (2013-2018)
7.5 India Cancer Supportive Care Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer Supportive Care Sales and Growth Rate (2013-2018)
8 South America Cancer Supportive Care by Countries
8.1 South America Cancer Supportive Care Sales, Revenue and Market Share by Countries
8.1.1 South America Cancer Supportive Care Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cancer Supportive Care Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cancer Supportive Care Sales and Growth Rate (2013-2018)
8.3 Argentina Cancer Supportive Care Sales and Growth Rate (2013-2018)
8.4 Colombia Cancer Supportive Care Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cancer Supportive Care by Countries
9.1 Middle East and Africa Cancer Supportive Care Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cancer Supportive Care Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cancer Supportive Care Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cancer Supportive Care Sales and Growth Rate (2013-2018)
9.3 UAE Cancer Supportive Care Sales and Growth Rate (2013-2018)
9.4 Egypt Cancer Supportive Care Sales and Growth Rate (2013-2018)
9.5 Nigeria Cancer Supportive Care Sales and Growth Rate (2013-2018)
9.6 South Africa Cancer Supportive Care Sales and Growth Rate (2013-2018)
10 Global Cancer Supportive Care Market Segment by Type
10.1 Global Cancer Supportive Care Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cancer Supportive Care Sales and Market Share by Type (2013-2018)
10.1.2 Global Cancer Supportive Care Revenue and Market Share by Type (2013-2018)
10.2 Nonsteroidal Erythropoietin Stimulating Agents Sales Growth and Price
10.2.1 Global Nonsteroidal Erythropoietin Stimulating Agents Sales Growth (2013-2018)
10.2.2 Global Nonsteroidal Erythropoietin Stimulating Agents Price (2013-2018)
10.3 Opioid Analgesics Sales Growth and Price
10.3.1 Global Opioid Analgesics Sales Growth (2013-2018)
10.3.2 Global Opioid Analgesics Price (2013-2018)
10.4 Anti-Imflammatory Drugs Sales Growth and Price
10.4.1 Global Anti-Imflammatory Drugs Sales Growth (2013-2018)
10.4.2 Global Anti-Imflammatory Drugs Price (2013-2018)
10.5 Anti-Infective Drugs Sales Growth and Price
10.5.1 Global Anti-Infective Drugs Sales Growth (2013-2018)
10.5.2 Global Anti-Infective Drugs Price (2013-2018)
10.6 Bisphosphonates Sales Growth and Price
10.6.1 Global Bisphosphonates Sales Growth (2013-2018)
10.6.2 Global Bisphosphonates Price (2013-2018)
10.7 Anti-Emetics Drugs Sales Growth and Price
10.7.1 Global Anti-Emetics Drugs Sales Growth (2013-2018)
10.7.2 Global Anti-Emetics Drugs Price (2013-2018)
10.8 Monoclonal Antibodies Sales Growth and Price
10.8.1 Global Monoclonal Antibodies Sales Growth (2013-2018)
10.8.2 Global Monoclonal Antibodies Price (2013-2018)
10.9 Granulocyte Colony Stimulating Factor Sales Growth and Price
10.9.1 Global Granulocyte Colony Stimulating Factor Sales Growth (2013-2018)
10.9.2 Global Granulocyte Colony Stimulating Factor Price (2013-2018)
11 Global Cancer Supportive Care Market Segment by Application
11.1 Global Cancer Supportive Care Sales Market Share by Application (2013-2018)
11.2 Lung Cancer Sales Growth (2013-2018)
11.3 Breast Cancer Sales Growth (2013-2018)
11.4 Prostate Cancer Sales Growth (2013-2018)
11.5 Liver Cancer Sales Growth (2013-2018)
11.6 Bladder Cancer Sales Growth (2013-2018)
11.7 Leukemia Sales Growth (2013-2018)
11.8 Ovarian Cancer Sales Growth (2013-2018)
11.9 Melanoma Sales Growth (2013-2018)
11.10 Others Sales Growth (2013-2018)
12 Cancer Supportive Care Market Forecast (2018-2023)
12.1 Global Cancer Supportive Care Sales, Revenue and Growth Rate (2018-2023)
12.2 Cancer Supportive Care Market Forecast by Regions (2018-2023)
12.2.1 North America Cancer Supportive Care Market Forecast (2018-2023)
12.2.2 Europe Cancer Supportive Care Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cancer Supportive Care Market Forecast (2018-2023)
12.2.4 South America Cancer Supportive Care Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cancer Supportive Care Market Forecast (2018-2023)
12.3 Cancer Supportive Care Market Forecast by Type (2018-2023)
12.3.1 Global Cancer Supportive Care Sales Forecast by Type (2018-2023)
12.3.2 Global Cancer Supportive Care Market Share Forecast by Type (2018-2023)
12.4 Cancer Supportive Care Market Forecast by Application (2018-2023)
12.4.1 Global Cancer Supportive Care Sales Forecast by Application (2018-2023)
12.4.2 Global Cancer Supportive Care Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Cancer Supportive Care Picture
Table Product Specifications of Cancer Supportive Care
Figure Global Sales Market Share of Cancer Supportive Care by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
